Originally developed to manage type 2 diabetes, semaglutide GLP-1 works as a glucagon-like peptide-1 (GLP-1) receptor agonist
In our analysis, we used fasting serum samples collected at baseline and end of treatment in a large subset of participants from two randomized, double-blind, placebo-controlled phase 3 trials, STEP 1 and STEP 2, to investigate the effects of semaglutide treatment on the circulating proteome
Independent Wellness includes provider-supervised lab review through Quest Diagnostics when relevant, plus ongoing care and plan adjustments
Suspicious lesions should be removed for histology using a full-thickness excision biopsy , typically with a narrow clinical margin where feasible
Until it reports and a regulator reviews it, there is no approval and no confirmed long-term safety verdict that is the central evidence gap
Many people end up taking medications to help them feel better when all they really need is to optimize their nutrition